Stock PIRS PIERIS PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Insiders Pieris Pharmaceuticals Inc OTC Bulletin Board

Equities

PIRS

US7207951036

End-of-day quote OTC Bulletin Board
Other stock markets
- - Intraday chart for Pieris Pharmaceuticals Inc
Apr. 19 Pieris Pharmaceuticals Shares Fall After 1-for-80 Reverse Stock Split Announcement MT
Apr. 03 North American Morning Briefing : Powell Awaited -2- DJ

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Prime Medicine Names Foghorn Therapeutics' CFO to be its New Finance Chief
MT
Vicore Pharma's New CEO to Formally Take Office
MT
Sweden’s Hansa Biopharma Appoints New Chief Scientific Officer
MT
Pieris Pharmaceuticals, Inc. Announces Executive Changes
CI
Pieris Pharmaceuticals, Inc. Announces Tim Demuth Steps Down as Senior Vice President and Chief Medical Officer, Effective September 30, 2022
CI
Pieris Pharmaceuticals : Promotes Thomas Bures to CFO
MT
Pieris Pharmaceuticals, Inc. Announces the Promotion of Ahmed Mousa to Chief Business Officer
CI
Pieris Pharmaceuticals, Inc. Announces Resignation of Dr. Jean-Pierre Bizzari from Board of Directors
CI
Louis Matis to Step Down as Senior Vice President and Chief Development Officer, Effective January 10, 2020
CI
Pieris Pharmaceuticals, Inc. Announces Management Changes
CI
Pieris Pharmaceuticals, Inc. Appoints Maya Said as Class II Director, Member of Nominating and Corporate Governance Committee and Science and Technology Committee of the Board
CI
Pieris Pharmaceuticals, Inc. Announces Retirement of Steven Prelack from the Board
CI
Pieris Pharmaceuticals Appoints Matthew L. Sherman to its Board of Directors
CI
Pieris Pharmaceuticals, Inc. Appoints Peter Kiener, D.Phil. to it's Board of Directors
CI
Pieris Pharmaceuticals, Inc. Appoints Ann Barbier to Board of Directors
CI
Pieris Pharmaceuticals, Inc. Announces Board Changes
CI
Pieris Pharmaceuticals, Inc. Appoints Ingmar Bruns as Vice President of Clinical Development
CI
Pieris Pharmaceuticals, Inc. Appoints Allan Reine as Senior Vice President and Chief Financial Officer
CI
Pieris Pharmaceuticals, Inc. Appoints James Geraghty as Board of Directors
CI
Pieris Pharmaceuticals, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PIRS Stock
  4. PIRS Stock
  5. News Pieris Pharmaceuticals Inc
  6. Insiders